Get started Log in

IMU — Imugene Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Market Cap
AU$15.80m
Enterprise Value
AU$19.47m
Revenue

Brief: Imugene Says FDA Fast Track Designation Granted For CF33-HNIS (Vaxinia) Mast Clinical Program
28/11/2023 01:42
Australia's Imugene eyes record weekly gain on cancer-killing virus study
10/11/2023 24:52
Australia's Imugene doubles in four days after positive cancer drug study
09/11/2023 04:19
Australia's Imugene extends gains on positive early signs in cancer drug study
07/11/2023 02:51
Australia's Imugene up on positive early signs in cancer drug study
06/11/2023 02:49
Brief: Imugene Ltd Says Azer-Cel FDA Ind Transferred To Imugene
28/09/2023 02:18
Australia's Imugene rises on $11.7 mln capital raise plan
25/09/2023 02:33
Brief: Imugene Posts Net Loss For Year Attributable Of A$39.2 Mln
25/08/2023 02:35
Brief: Imugene Completes A$35M Placement
18/08/2023 02:17
Australia's Imugene hits near 3-year low on discounted share placement
18/08/2023 01:45
Precision BioSciences falls after selling rights for lead therapy to Imugene
16/08/2023 16:21
Refinitiv Newscasts - U.S. Morning Call: Higher-for-longer rates regime pressures US recession trades
16/08/2023 12:33
Precision BioSciences up on completing cancer therapy agreement with Imugene
16/08/2023 11:10
Brief: Imugene Licenses Allogeneic Cd19 Car T Cell Therapy
16/08/2023 01:58
Brief: Imugene Seeks Trading Halt
15/08/2023 23:46
Brief: RenovoRx, Imugene Announce Collaboration To Deliver Oncolytic Virus Therapy
20/07/2023 13:19
Brief: Imugene Announce Strategic Research Collaboration
20/07/2023 02:43
Australia's Imugene hits 1-1/2-month high on collaboration with RenovoRx
20/07/2023 02:24
Australia's Imugene jumps on US patent for virus-based cancer therapy
19/07/2023 06:19
Imugene Ltd gains after therapy indicate tumour reduction in phase 2 study
30/06/2023 01:57